Active Pharmaceuticals ID'd in >700 Dietary Supplements

Category: Cardiology | Dermatology | Endocrinology | Family Medicine | Geriatrics | Gastroenterology | Gynecology | Infections | AIDS | Internal Medicine | Allergy | Emergency Medicine | Nephrology | Neurology | Nursing | Oncology | Ophthalmology | Orthopedics | ENT | Pharmacy | Psychiatry | Pulmonology | Rheumatology | Urology | Anesthesiology & Pain […]

Active Pharmaceutical Ingredient Market: Evolving Technology, Trends and Industry Analysis 2023

Active Pharmaceutical Ingredient Market Report provides key statistics on the market status of the Active Pharmaceutical Ingredient Manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Active Pharmaceutical Ingredient Industry. In Active Pharmaceutical Ingredient Market report, there is a section for competition landscape of the global Active […]

Hundreds of diet supplements spiked with hidden pharmaceuticals

Hundreds of dietary supplements available for sale in America between 2007 and 2016 contained “active pharmaceuticals” – drugs – that can have serious adverse affects, according to a review of data from the US Food and Drug Administration (FDA). The tainted supplements “have the potential to cause serious adverse health effects,” wrote the authors, led […]

Crescita's Patented Delivery Technologies Demonstrate Enhanced Skin Permeation of Cannabidiol

LAVAL, QC, Oct. 15, 2018 /PRNewswire/ – Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases and their symptoms, is pleased to announce that its patented transdermal delivery technologies: Multiplexed Molecular […]

Asian stocks resume slide amid concerns about US-China trade

Asian stocks resume slide amid concerns about US-China trade

HONG KONG (Nikkei Markets) — Asian stocks outside of Japan resumed losses on Monday as worries over U.S.-China trade tensions continue to cloud investor sentiment. The Nikkei Asia300 Index fell 0.95% to 1,197.84 following a 2.6% advance on Friday. The day’s losses came despite an advance on Wall Street on Friday as market participants remained […]

Hundreds of dietary supplements contain potentially 'dangerous' ingredients, finds study

Hundreds of dietary supplements contain potentially 'dangerous' ingredients, finds study

Hundreds of dietary supplements sold over the counter in the US contain unapproved and potentially dangerous drugs, a new study has found.  Researchers from the California Department of Public Health found that, from 2007 to 2016, 776 products marketed as dietary supplements contained hidden ingredients that are unsafe or unstudied. Among them were dapoxetine, an […]

Global Small Molecule Active Pharmaceutical Ingredient Market 2018- Patheon NV, AstraZeneca, Johnson & Johnson …

Global Small Molecule Active Pharmaceutical Ingredient Market 2018- Patheon NV, AstraZeneca, Johnson & Johnson …

The extensive enlightenments regarding Global Small Molecule Active Pharmaceutical Ingredient Market 2018 along with analytical data of driving factors of industry, contemporary market trends, segments, applications, and types, as well as region-wise analysis is instilled in the Global Keyword Market Report. Primarily the report centers over the tendency of the Small Molecule Active Pharmaceutical Ingredient market and […]

Dr Reddy's Labs to sell bulk-drugs plant to BR Shetty-led Neopharma's JV

Dr Reddy's Labs to sell bulk-drugs plant to BR Shetty-led Neopharma's JV

Drugmaker Dr Reddy’s Laboratories Ltd on Monday said it has entered into a definitive agreement to sell its active pharmaceutical ingredient (API) plant in Hyderabad to Indian generics pharma company Therapiva Pvt Ltd. The sale of the unit is part of the company’s plan to streamline manufacturing and reduce costs, said Sanjay Sharma, executive vice-president […]

Dr Reddy's to sell Hyderabad API unit to Therapiva

Dr Reddy's to sell Hyderabad API unit to Therapiva

New Delhi, Oct 15 () Drug major Dr Reddy’s Laboratories (DRL) Monday said it will sell its active pharmaceutical ingredient (API) business unit in Hyderabad to generics pharmaceutical company Therapiva Private Ltd. In a regulatory filing, Dr Reddy’s Laboratories said it has entered into a definitive agreement for the sale of its API manufacturing business […]

Dr Reddy's signs definitive agreement to sell its API business in Hyderabad

Dr Reddy's signs definitive agreement to sell its API business in Hyderabad

Dr Reddy’s Laboratories on Monday said it had signed a definitive agreement to sell its active pharmaceutical ingredient (API) manufacturing business unit located in Jeedimetla, Hyderabad, to Therapiva Pvt Ltd, an emerging generics pharmaceutical company. The divestiture by way of slump sale includes all related fixed assets, current assets, current liabilities, […]